Log in
Enquire now
‌

US Patent 11286275 Nucleic acid compound and oligonucleotide

Patent 11286275 was granted and assigned to Osaka University on March, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Osaka University
Osaka University
0
Current Assignee
Osaka University
Osaka University
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
112862750
Patent Inventor Names
Kosuke Ito0
Takaki Habuchi0
Satoshi Obika0
Masahiko Horiba0
Date of Patent
March 29, 2022
0
Patent Application Number
164877850
Date Filed
February 20, 2018
0
Patent Citations Received
‌
US Patent 11905308 Nucleic acid compound and oligonucleotide
0
Patent Primary Examiner
‌
Amy H Bowman
0
CPC Code
‌
C12N 15/113
0

The present invention aims to provide a nucleic acid compound that hardly forms non-Watson-Crick base pairs, and an oligonucleotide containing the nucleic acid compound and showing reduced non-specific binding with nucleic acids other than the target nucleic acid. The nucleic acid compound according to the present invention is characterized in that the 2-position carbonyl group of the pyrimidine base is functionally converted (X

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11286275 Nucleic acid compound and oligonucleotide

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.